8-Aryl xanthines potent inhibitors of phosphodiesterase 5-Reference-Cited by-同舟云学术

8-Aryl xanthines potent inhibitors of phosphodiesterase 5

Published:2002-09 Issue:18 Volume:12 Page:2587-2590
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Arnold Ruth,Beer David,Bhalay Gurdip,Baettig Urs,Collingwood Stephen P,Craig Sarah,Devereux Nicholas,Dunstan Andrew,Glen Angela,Gomez Sylvie,Haberthuer Sandra,Howe Trevor,Jelfs Stephen,Moser Heinz,Naef Reto,Nicklin Paul,Sandham David,Stringer Rowan,Turner Katharine,Watson Simon,Zurini Mauro

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference15 articles.

1. Maw, G. N. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic: New York, 1999; p 71.

2. Pharmacotherapy for erectile dysfunction

3. Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

4. Phosphodiesterase type 5 inhibitors: Discovery and therapeutic utility

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing of xanthine-based DPP-4 inhibitors: a structure-guided alignment dependent Multifacet 3D-QSAR modeling, and molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2024-05-24

2. The efficacy of topical aminophylline in local fat reduction: A systematic review;Frontiers in Endocrinology;2023-02-16

3. Application of diazonium chemistry in purine modifications: A focused review;Journal of Heterocyclic Chemistry;2021-08-09

4. Synthesis, Biological Validation, and Docking Studies of Novel Purine Derivatives Containing Pyridopyrimidine, Pyrazolopyridine, and Pyranonapthyridine Rings†;Polycyclic Aromatic Compounds;2021-01-15

5. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents;European Journal of Medicinal Chemistry;2019-08